Related references
Note: Only part of the references are listed.Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy
Daniel J. Canter et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer
Benjamin E. Cedars et al.
JOURNAL OF UROLOGY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy
Daniel E. Spratt et al.
EUROPEAN UROLOGY (2018)
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease
Stephen K. Van Den Eeden et al.
EUROPEAN UROLOGY (2018)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
Martin G. Sanda et al.
JOURNAL OF UROLOGY (2018)
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort
Jennifer Cullen et al.
EUROPEAN UROLOGY FOCUS (2018)
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
Paul L. Nguyen et al.
EUROPEAN UROLOGY (2017)
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E. Spratt et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Enriching gene expression profiles will help personalize prostate cancer management for African-Americans: A perspective
Srinivasan Vijayakumar et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao et al.
JAMA ONCOLOGY (2017)
Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer
A. E. Ross et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Use of the cell cycle progression (CCP) score for predicting systemic disease and response to radiation of biochemical recurrence
Michael O. Koch et al.
CANCER BIOMARKERS (2016)
Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
Sungyong You et al.
CANCER RESEARCH (2016)
Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location
Farzana A. Faisal et al.
EUROPEAN UROLOGY (2016)
Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
Ashley E. Ross et al.
EUROPEAN UROLOGY (2016)
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
A. E. Ross et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen et al.
EUROPEAN UROLOGY (2015)
Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2015)
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
Kosj Yamoah et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy
Robert B. Den et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort
Alexis R. Gaines et al.
CANCER CAUSES & CONTROL (2014)
Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy
Alberto Briganti et al.
EUROPEAN UROLOGY (2014)
Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men
Isaac J. Powell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
Stephen J. Freedland et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
R. Jeffrey Karnes et al.
JOURNAL OF UROLOGY (2013)
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho et al.
PLOS ONE (2013)
Effect of Race and Socioeconomic Status on Surgical Margins and Biochemical Outcomes in an Equal-Access Health Care Setting Results From the Shared Equal Access Regional Cancer Hospital (SEARCH) Database
David I. Chu et al.
CANCER (2012)
A single-sample microarray normalization method to facilitate personalized-medicine workflows
Stephen R. Piccolo et al.
GENOMICS (2012)
Exon array data analysis using Affymetrix power tools and R statistical software
Helen E. Lockstone
BRIEFINGS IN BIOINFORMATICS (2011)
The CAPRA-S Score A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy
Matthew R. Cooperberg et al.
CANCER (2011)
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men
H. S. Kim et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Tumor immunobiological differences in prostate cancer between African-American and European-American men
Tiffany A. Wallace et al.
CANCER RESEARCH (2008)
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Margaret S. Pepe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
